Evidence map›Paper›PMID 20648231›Full record

ArticleDrug discovery today. Disease mechanisms2009

CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE.

Shruti Sharma, Stephen M Black

Abstract read
In one paragraph

Article in Drug discovery today. Disease mechanisms, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 161 citations in OpenAlex.

  1. Trial
  2. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti-inflammatory and insulin-sensitizing properties.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Trial
  3. Review
  4. Observational
  5. Article
  6. Early Sepsis Metabolic Changes in Kidney and Liver Precede Clinical Evidence of Organ Dysfunction.American journal of respiratory cell and molecular biology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shruti SharmaThe Pulmonary Disease Program, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912.
Stephen M Black
Augusta University · US

Funding

PERINATAL REGULATION OF THE ENDOTHELIAL NOS GENER01HL060190 · NHLBI · UNIVERSITY OF MONTANA · PI Stephen M Black · 1998 to 2026
$7.1M
ROS in Pulmonary Hypertension: Role of ADMAR01HL067841 · NHLBI · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 2002 to 2011
$2.6M
THE ROLE OF NEURONAL NOS DIMERIZATION IN NEUROTOXICITYR01HD039110 · NICHD · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 1999 to 2010
$2.0M
NO-mediated signaling in endothelial cellsR01HL070061 · NHLBI · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 2003 to 2006
$1.6M
Perinatal regulation of TGF-beta1 during vascular remodelingR01HL084739 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2007 to 2010
$1.5M
Role of altered carnitine metabolism in perinatal endothelial dysfunctionR21HD057406 · NICHD · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2008 to 2009
$423k
NHLBI NIH HHS R01 HL060190NHLBI NIH HHS R01 HL067841NHLBI NIH HHS R01 HL070061NHLBI NIH HHS R01 HL084739NICHD NIH HHS R01 HD039110NICHD NIH HHS R21 HD057406
6 · The paper itself

Abstract

Carnitines are involved in mitochondrial transport of fatty acids and are of critical importance for maintaining normal mitochondrial function. This review summarizes recent experimental and clinical studies showing that mitochondrial dysfunction secondary to a disruption of carnitine homeostasis may play a role in decreased NO signaling and the development of endothelial dysfunction. Future challenges include development of agents that can positively modulate L-carnitine homeostasis which may have high therapeutic potential.

Identifiers

PMID20648231
PMCPMC2905823
OpenAlexW2103013051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.